Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination.
Orrù V, Serra V, Marongiu M, Lai S, Lodde V, Zoledziewska M, Steri M, Loizedda A, Lobina M, Piras MG, Virdis F, Delogu G, Marini MG, Mingoia M, Floris M, Masala M, Castelli MP, Mostallino R, Frau J, Lorefice L, Farina G, Fronza M, Carmagnini D, Carta E, Pilotto S, Chessa P, Devoto M, Castiglia P, Solla P, Zarbo RI, Idda ML, Pitzalis M, Cocco E, Fiorillo E, Cucca F.
Orrù V, et al. Among authors: mingoia m.
Front Immunol. 2024 Jul 15;15:1416464. doi: 10.3389/fimmu.2024.1416464. eCollection 2024.
Front Immunol. 2024.
PMID: 39076966
Free PMC article.